Results 21 to 30 of about 966,359 (290)

Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile [PDF]

open access: yesIntestinal Research
Background/Aims Fecal microbiota transplantation (FMT) is increasingly recognized as an alternative to antibiotics for treating recurrent Clostridioides difficile infection.
Ki Sung Kang   +7 more
doaj   +1 more source

Clostridium difficile Infection in Children [PDF]

open access: yesJAMA Pediatrics, 2013
Clostridium difficile is the most common cause of health care-associated diarrhea among adults in the United States and is associated with significant morbidity and mortality. During the past decade, the epidemiology of C difficile infection (CDI) has changed, including a rise in the rate and severity of infection related to the emergence of a ...
Julia Shaklee, Sammons   +2 more
openaire   +2 more sources

Botulism-like symptoms in an immunocompetent patient with Clostridium subterminale bacteremia

open access: yesIDCases, 2018
Clostridium subterminale is a low virulence species of Clostridium that is an infrequent cause of human infections. We report a case of C. subterminale bacteremia in an immunocompetent patient who developed botulism-like symptoms.
Marytere Carrasquillo   +2 more
doaj   +1 more source

Modelling the transmission of healthcare associated infections: a systematic review. [PDF]

open access: yes, 2013
BACKGROUND: Dynamic transmission models are increasingly being used to improve our understanding of the epidemiology of healthcare-associated infections (HCAI). However, there has been no recent comprehensive review of this emerging field.
Edmunds, William J   +9 more
core   +2 more sources

Clostridium sporogenes bacteremia in an immunocompetent patient

open access: yesIDCases, 2019
Of the 200 Clostridium spp. known to exist, approximately 30 have been associated with human disease. Commonly found in soil, marine sediment and mammalian intestinal tracts, these gram-positive bacilli are known to cause infections ranging from ...
Waiel Abusnina   +4 more
doaj   +1 more source

Clostridium perfringensepsilon toxin H149A mutant as a platform for receptor binding studies [PDF]

open access: yes, 2013
Clostridium perfringens epsilon toxin (Etx) is a pore-forming toxin responsible for a severe and rapidly fatal enterotoxemia of ruminants. The toxin is classified as a category B bioterrorism agent by the U.S.
Titball, R.W.   +21 more
core   +1 more source

The Recent Emergence of Clostridium difficile Infection in Romanian Hospitals is Associated with a High Prevalence of Polymerase Chain Reaction Ribotype 027

open access: yesBalkan Medical Journal, 2018
Aims: To investigate the epidemiology of Clostridium difficile infection in Romanian hospitals. Methods: A survey was conducted at nine hospitals throughout Romania between November 2013 and February 2014.
Gabriel Adrian Popescu   +8 more
doaj   +1 more source

Results from the second Scottish national prevalence survey: the changing epidemiology of healthcare-associated infection in Scotland [PDF]

open access: yes, 2012
Healthcare-associated infections (HAIs) are a recognized public health problem worldwide. Point prevalence surveys (PPSs) can be used to measure the burden of all HAI types.
Reilly, J.   +8 more
core   +4 more sources

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. [PDF]

open access: yes, 2012
Introduction Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI).
Sutton, AJ   +77 more
core   +1 more source

Probiotics in Clostridium difficile Infection [PDF]

open access: yesJournal of Clinical Gastroenterology, 2011
Clostridium difficile infection (CDI) is one of the most prevalent nosocomial infections. A dramatic increase in the incidence and severity of CDI has been noted in the past decade. Current recommendations suggest metronidazole as first-line therapy in mild to moderately severe CDI and oral vancomycin in individuals with severe CDI, or when ...
Xi, Na, Ciaran, Kelly
openaire   +2 more sources

Home - About - Disclaimer - Privacy